a year ago
FUSN
AnalystsRahul SarugaserRahul Sarugaser's Stock Forecasts
AnalystsRahul Sarugaser
Sectors:
Industries:
Analyst Ranking
Top 15%
#731 out of 4875 analysts
Average Return
+123.71%
Win Rate
60%6 out of 10
Risk vs Reward
Poor
Good
Rahul Sarugaser's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +595.16% | $3.10 | $21.55 | 2023-08-28 - 2024-06-03 | Buy |
Fusion Pharmaceuticals IncFUSN | +379.96% | $4.49 | $21.55 | 2023-06-23 - 2024-06-03 | Buy |
Fusion Pharmaceuticals IncFUSN | +158.24% | $8.35 | $21.55 | 2024-01-05 - 2024-06-03 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +137.33% | $9.08 | $21.55 | 2023-12-27 - 2024-06-03 | Strong Buy |
Point Biopharma Global IncPNT | +109.57% | $6.79 | $14.23 | 2022-12-14 - 2023-12-13 | Buy |
Rahul Sarugaser Analyst Color
Get additional color on Rahul Sarugaser's coverage of popular stocks
a year ago
FUSN
3 years ago
DNA
Rahul Sarugaser's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oncolytics Biotech IncONCY | 1 | Buy | $3.00 | N/A | Initiates Coverage On | a year ago |
Quipt Home Medical CorpQIPT | 1 | Hold | $10.00 | N/A | Downgrades | a year ago |
Fusion Pharmaceuticals IncFUSN | 4 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Ginkgo Bioworks Holdings IncDNA | 4 | Hold | $100.00 | N/A | Downgrades | a year ago |
Village Farms International IncVFF | 2 | Hold | $2.50 | N/A | Downgrades | 2 years ago |
Point Biopharma Global IncPNT | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Profound Medical CorpPROF | 1 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.